Related Experiment Video
Updated: Apr 20, 2026
09:14
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
4.9K
Epstein-barr virus sequence variation-biology and disease.
Stelios Tzellos1, Paul J Farrell2
1Section of Virology, Imperial College Faculty of Medicine, Norfolk Place, London W2 1PG, UK. stelios.tzellos06@imperial.ac.uk.
Pathogens (Basel, Switzerland)
|December 2, 2014
Summary
Epstein-Barr virus (EBV) sequence variations influence infection and disease. Understanding EBV genetic diversity is crucial for developing effective EBV vaccines and treatments for EBV-associated illnesses.
Area of Science:
- Virology
- Genetics
- Immunology
Background:
- Epstein-Barr virus (EBV) sequence variations are key to understanding infection and disease.
- Current EBV classification relies on EBNA2 gene sequence, dividing isolates into Type 1 and Type 2.
- Type 1 EBV is globally prevalent and transforms B cells more efficiently than Type 2 EBV.
Purpose of the Study:
- To investigate the impact of naturally occurring EBV sequence differences on infection and associated diseases.
- To explore the importance of EBV sequence variation for potential EBV vaccine development.
- To understand the molecular mechanisms behind differential B cell transformation by EBV types.
Main Methods:
- Analysis of EBV isolates worldwide.
- Classification based on EBNA2 gene sequence.
- Investigation of EBV genome data and regional variations.
Main Results:
- EBV isolates are classified as Type 1 or Type 2 based on EBNA2 gene sequence.
- Type 1 EBV demonstrates higher efficiency in transforming human B cells compared to Type 2.
- Emerging evidence links specific EBV gene mutations, like in EBNA3B, to diseases such as diffuse large B cell lymphoma.
Conclusions:
- Naturally occurring EBV sequence variations play a significant role in infection and disease pathogenesis.
- Advancements in sequencing technology will enable comprehensive studies of EBV regional variation and its link to disease.
- Understanding EBV genetic diversity is essential for developing targeted therapies and preventative strategies, including vaccines.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
3.0K
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
9.8K
Related Concept Videos
00:36Viral Mutations
41.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
41.1K
00:57Viral Recombination
25.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.9K
01:26Size and Structure of Viral Genomes
1.2K
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
1.2K
01:05Single Nucleotide Polymorphisms-SNPs
20.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.5K
02:26Comparing Copy Number Variations and SNPs
19.4K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.4K
01:29Viruses of Archaea
691
Archaeal viruses play a crucial role in the ecosystems of extremophilic archaea, particularly those belonging to the phyla Euryarchaeota and Crenarchaeota. By shaping host evolution and facilitating gene transfer, these viruses influence microbial communities and contribute to genetic diversity in extreme environments. The archaea they infect thrive in acidic hot springs and hydrothermal vents characterized by high temperatures and low pH. Archaeal viruses exhibit remarkable structural...
691